These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23659864)

  • 21. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction.
    Hein M; Roehl AB; Baumert JH; Scherer K; Steendijk P; Rossaint R
    Acta Anaesthesiol Scand; 2009 Aug; 53(7):941-8. PubMed ID: 19426242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of kappa opioid receptors in cardioprotection against ischemia: the signaling mechanisms.
    Wong TM; Wu S
    Sheng Li Xue Bao; 2003 Apr; 55(2):115-20. PubMed ID: 12715097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study.
    Meco M; Cirri S; Gallazzi C; Magnani G; Cosseta D
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):319-25. PubMed ID: 17574858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New pharmacologic options in the treatment of acute coronary syndromes and myocardial ischemia-reperfusion injury: potential role of levosimendan.
    Garcia-Gonzalez MJ; Dominguez-Rodriguez A; Abreu-Gonzalez P
    Minerva Cardioangiol; 2007 Oct; 55(5):625-35. PubMed ID: 17912166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protecting the heart from ischemia: an update on ischemic and pharmacologic conditioning.
    Gerczuk PZ; Kloner RA
    Hosp Pract (1995); 2011 Aug; 39(3):35-43. PubMed ID: 21881390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of apoptosis in ischemic myocardium.
    Scarabelli TM; Knight R; Stephanou A; Townsend P; Chen-Scarabelli C; Lawrence K; Gottlieb R; Latchman D; Narula J
    Curr Probl Cardiol; 2006 Mar; 31(3):181-264. PubMed ID: 16503249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF-alpha is required for late ischemic preconditioning but not for remote preconditioning of trauma.
    Ren X; Wang Y; Jones WK
    J Surg Res; 2004 Sep; 121(1):120-9. PubMed ID: 15313385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial protection at a crossroads: the need for translation into clinical therapy.
    Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
    Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest.
    Thielmann M; Kottenberg E; Boengler K; Raffelsieper C; Neuhaeuser M; Peters J; Jakob H; Heusch G
    Basic Res Cardiol; 2010 Sep; 105(5):657-64. PubMed ID: 20495811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial overview: cardioprotective drugs for myocardial ischemic injury--a therapeutic area at risk.
    Knight DR
    Curr Opin Investig Drugs; 2007 Mar; 8(3):190-2. PubMed ID: 17408113
    [No Abstract]   [Full Text] [Related]  

  • 32. Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heart.
    Dow J; Bhandari A; Kloner RA
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):141-8. PubMed ID: 18495906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists.
    Kato R; Foëx P
    Can J Anaesth; 2002 Oct; 49(8):777-91. PubMed ID: 12374705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection.
    Caricati-Neto A; Errante PR; Menezes-Rodrigues FS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ischemic preconditioning of the myocardium: the role of changes in the permeability of the coronary microcirculation].
    Di Napoli P; Di Muzio M; Contegiacomo G; Tiloca P; Spoletini L; Di Crecchio A; Gallina S; Barsotti A
    Cardiologia; 1997 Jan; 42(1):59-67. PubMed ID: 9118156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective effect of ApolipoproteinA-I on myocardial ischemia-reperfusion injury in rats.
    Gu SS; Shi N; Wu MP
    Life Sci; 2007 Aug; 81(9):702-9. PubMed ID: 17698150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats.
    Houshmand F; Faghihi M; Zahediasl S
    Peptides; 2009 Dec; 30(12):2301-8. PubMed ID: 19761809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic injection of PARP inhibitor INO-1001 preserves cardiac function in porcine myocardial ischemia and reperfusion without reducing infarct size.
    Roesner JP; Mersmann J; Bergt S; Bohnenberg K; Barthuber C; Szabo C; Nöldge-Schomburg GE; Zacharowski K
    Shock; 2010 May; 33(5):507-12. PubMed ID: 20395771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant early and late cardioprotective therapy: access to the heart.
    Hinkel R; Boekstegers P; Kupatt C
    Cardiovasc Res; 2012 May; 94(2):226-36. PubMed ID: 22318936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.